Soft Landing Labs, LTD. is expanding its testing capabilities beyond drug testing.
GlobeNewswire - Thu May 22, 1:09PM CDT
via PRWEB - SLNZ is expanding its testing capabilities beyond drug testing to include, metabolomics, proteomic and possibly genomics. Proteomics is the study of the full array of proteins present in human cells and is the natural extension of genomics. This evolving field has a tremendous potential to change the practice of medicine.